About this trial
This study aims to explore the dynamic changes in different cell types and their molecular regulatory mechanisms during the healing process of peri-implant soft tissues, using single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST).
The research will focus specifically on the healing of soft tissues around dental implants in human subjects with the use of a healing abutment. Participants in the healing abutment group will have a micro healing abutment placed immediately after implant placement.
Tissue samples will be collected at various time points (Day 4, Day 14, and Day 70) to construct a detailed single-cell map of the healing process.
Spatial transcriptomics will be integrated to preserve tissue architecture, enabling the identification of the spatial distribution of different cell types and their interactions within the peri-implant microenvironment.
This combined approach will allow for a comprehensive characterization of cellular interactions, spatial gene expression patterns, and regulatory networks specific to healing abutments.
The goal is to identify key regulatory factors that could improve peri-implant soft tissue healing and help prevent peri-implantitis.
Eligibility criteria
Qualifiers
Age: 18-65 years
Healthy individuals without chronic medical conditions or severe systemic diseases
Able to comply with study requirements (e.g., follow-up visits)
No history of periodontal disease or active infection
Disqualifiers
Individuals with systemic conditions that affect wound healing (e.g., diabetes, immunosuppressive therapy)
Smoking or alcohol abuse
Pregnant or breastfeeding women
History of severe allergic reactions to implant materials
Trial design
Treatments tested in this trial
- Healing Abutment Gingival Healing Post-Implantation